×
S&P 500   3,810.73 (-0.38%)
DOW   30,796.34 (-0.97%)
QQQ   286.17 (+1.43%)
AAPL   141.37 (+1.76%)
MSFT   261.86 (+0.88%)
META   167.28 (+4.53%)
GOOGL   2,261.33 (+3.98%)
AMZN   114.02 (+4.07%)
TSLA   695.51 (+2.01%)
NVDA   149.20 (+2.73%)
NIO   21.97 (+2.86%)
BABA   118.04 (+1.76%)
AMD   74.97 (+1.76%)
MU   56.52 (+5.35%)
CGC   2.68 (-4.63%)
T   21.07 (-1.13%)
GE   61.40 (-3.37%)
F   11.14 (-1.59%)
DIS   96.84 (+0.73%)
AMC   12.73 (-5.91%)
PFE   51.31 (-1.91%)
PYPL   74.41 (+4.22%)
NFLX   184.69 (+2.63%)
S&P 500   3,810.73 (-0.38%)
DOW   30,796.34 (-0.97%)
QQQ   286.17 (+1.43%)
AAPL   141.37 (+1.76%)
MSFT   261.86 (+0.88%)
META   167.28 (+4.53%)
GOOGL   2,261.33 (+3.98%)
AMZN   114.02 (+4.07%)
TSLA   695.51 (+2.01%)
NVDA   149.20 (+2.73%)
NIO   21.97 (+2.86%)
BABA   118.04 (+1.76%)
AMD   74.97 (+1.76%)
MU   56.52 (+5.35%)
CGC   2.68 (-4.63%)
T   21.07 (-1.13%)
GE   61.40 (-3.37%)
F   11.14 (-1.59%)
DIS   96.84 (+0.73%)
AMC   12.73 (-5.91%)
PFE   51.31 (-1.91%)
PYPL   74.41 (+4.22%)
NFLX   184.69 (+2.63%)
S&P 500   3,810.73 (-0.38%)
DOW   30,796.34 (-0.97%)
QQQ   286.17 (+1.43%)
AAPL   141.37 (+1.76%)
MSFT   261.86 (+0.88%)
META   167.28 (+4.53%)
GOOGL   2,261.33 (+3.98%)
AMZN   114.02 (+4.07%)
TSLA   695.51 (+2.01%)
NVDA   149.20 (+2.73%)
NIO   21.97 (+2.86%)
BABA   118.04 (+1.76%)
AMD   74.97 (+1.76%)
MU   56.52 (+5.35%)
CGC   2.68 (-4.63%)
T   21.07 (-1.13%)
GE   61.40 (-3.37%)
F   11.14 (-1.59%)
DIS   96.84 (+0.73%)
AMC   12.73 (-5.91%)
PFE   51.31 (-1.91%)
PYPL   74.41 (+4.22%)
NFLX   184.69 (+2.63%)
S&P 500   3,810.73 (-0.38%)
DOW   30,796.34 (-0.97%)
QQQ   286.17 (+1.43%)
AAPL   141.37 (+1.76%)
MSFT   261.86 (+0.88%)
META   167.28 (+4.53%)
GOOGL   2,261.33 (+3.98%)
AMZN   114.02 (+4.07%)
TSLA   695.51 (+2.01%)
NVDA   149.20 (+2.73%)
NIO   21.97 (+2.86%)
BABA   118.04 (+1.76%)
AMD   74.97 (+1.76%)
MU   56.52 (+5.35%)
CGC   2.68 (-4.63%)
T   21.07 (-1.13%)
GE   61.40 (-3.37%)
F   11.14 (-1.59%)
DIS   96.84 (+0.73%)
AMC   12.73 (-5.91%)
PFE   51.31 (-1.91%)
PYPL   74.41 (+4.22%)
NFLX   184.69 (+2.63%)
NASDAQ:CGEN

Compugen Earnings Date, Estimates & Call Transcripts (2022)

$2.06
+0.14 (+7.03%)
(As of 07/5/2022 02:32 PM ET)
Add
Compare
Today's Range
$1.87
$2.09
50-Day Range
$1.57
$2.50
52-Week Range
$1.55
$8.17
Volume
62,671 shs
Average Volume
606,374 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67

Earnings Summary

Upcoming
Earnings Date
Jul. 27Estimated
Actual EPS
(May. 16)
-$0.11 Beat By $0.01
Consensus EPS
(May. 16)
-$0.12
Last Year's Q2 EPS
(5/13/2021)
-$0.12
Skip Charts & View Estimated and Actual Earnings Data

CGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Compugen Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20222($0.16)($0.14)($0.15)
Q2 20223($0.12)($0.11)($0.11)
Q3 20223($0.13)($0.11)($0.12)
Q4 20223($0.15)($0.12)($0.13)
FY 202211($0.56)($0.48)($0.52)
Q1 20232($0.13)($0.13)($0.13)
Q2 20232($0.13)($0.13)($0.13)
Q3 20232($0.14)($0.12)($0.13)
Q4 20232($0.20)($0.15)($0.18)
FY 20238($0.60)($0.53)($0.57)

CGEN Earnings Date and Information

Compugen last released its quarterly earnings results on May 16th, 2022. The biotechnology company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.01. Compugen has generated ($0.39) earnings per share over the last year (($0.39) diluted earnings per share). Earnings for Compugen are expected to decrease in the coming year, from ($0.49) to ($0.58) per share. Compugen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 27th, 2022 based off prior year's report dates.

Compugen Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/27/2022
(Estimated)
        
5/16/20223/31/2022($0.12)($0.11)+$0.01
2/24/2022Q4 2021($0.15)($0.10)+$0.05($0.10)$0.86 million    
11/12/20219/30/2021($0.13)($0.07)+$0.06($0.07)$6.00 million    
7/28/20216/30/2021($0.12)($0.11)+$0.01($0.11)    
5/13/20213/31/2021($0.13)($0.12)+$0.01($0.12)  
2/25/202112/31/2020($0.10)($0.10)($0.10)$2.00 million  
11/5/20209/30/2020($0.09)($0.09)($0.09)  
7/30/20206/30/2020($0.10)($0.08)+$0.02($0.08)  
5/6/20203/31/2020($0.10)($0.10)($0.10)  
2/20/202012/31/2019($0.11)($0.10)+$0.01($0.10)  
11/11/20199/30/2019($0.11)($0.10)+$0.01($0.10)  
8/5/2019Q2($0.14)($0.10)+$0.04($0.10)
5/20/20193/31/2019($0.17)($0.14)+$0.03($0.14)  
2/26/2019Q4 2018($0.21)($0.16)+$0.05($0.16)
11/7/20189/30/2018($0.12)($0.05)+$0.07($0.05)$7.80 million$7.80 million  
8/1/20186/30/2018($0.19)($0.19)($0.19)
2/21/2018n/a($0.18)($0.18)($0.18)
11/7/2017Q3 2017($0.19)($0.19)($0.19)
8/2/20176/30/2017($0.17)($0.18)($0.01)($0.18)$0.21 million  
5/9/20173/31/2017($0.18)($0.17)+$0.01($0.17)$0.06 million  
2/15/2017Q416($0.18)($0.17)+$0.01($0.17)$0.13 million$0.05 million  
11/7/2016Q316($0.14)($0.15)($0.01)($0.15)$0.41 million$0.07 million
8/2/2016Q116($0.17)($0.13)+$0.04($0.13)$0.11 million$0.50 million
5/10/2016Q1($0.16)($0.17)($0.01)($0.17)$0.12 million$0.09 million  
2/9/2016Q415($0.11)($0.01)+$0.10($0.01)$3.33 million$8.30 million
11/3/2015Q315($0.15)($0.13)+$0.02($0.13)$0.92 million$0.23 million
8/4/2015Q215($0.14)($0.14)($0.14)$1.58 million$0.22 million
5/5/2015Q115($0.13)($0.12)+$0.01($0.12)$1.88 million$0.51 million
2/10/2015Q414($0.08)($0.03)+$0.05($0.03)$3.70 million$6.60 million
10/29/2014Q314($0.11)($0.11)($0.11)$1.90 million$1.70 million
8/6/2014Q214($0.10)($0.07)+$0.03($0.07)$1.85 million$2.00 million
5/19/2014Q114($0.11)($0.04)+$0.07($0.04)$0.16 million$2.10 million  
2/11/2014Q4 2013($0.09)($0.09)($0.09)$0.13 million$1.80 million
10/29/2013Q3 2013($0.12)($0.12)($0.12)$0.11 million$1.60 million  
8/2/2013Q2 2013($0.09)($0.09)($0.09)$0.02 million
4/25/2013Q1 2013($0.09)($0.09)($0.09)$0.16 million
2/20/2013Q4 2012($0.15)($0.15)($0.15)
11/5/2012Q312($0.10)($0.10)
8/7/2012Q2 2012($0.02)($0.02)($0.02)
5/1/2012Q1 2012($0.12)($0.12)($0.12)
2/7/2012Q4 2011($0.13)($0.13)($0.13)
11/8/2011Q3 2011($0.10)($0.10)($0.10)
8/2/2011Q2 2011($0.06)($0.06)($0.06)
5/11/2011Q1 2011($0.06)($0.06)($0.06)
2/15/2011Q4 2010($0.06)($0.06)($0.06)
10/26/2010Q3 2010($0.05)($0.05)($0.05)
7/27/2010Q2 2010($0.06)($0.03)+$0.03($0.03)
4/27/2010Q1 2010($0.05)($0.08)($0.03)($0.08)
2/9/2010Q4 2009($0.08)($0.07)+$0.01($0.07)
10/27/2009Q3 2009($0.07)($0.06)+$0.01($0.06)
7/28/2009Q2 2009$0.08+$0.08$0.08
5/12/2009Q1 2009($0.08)($0.08)($0.08)
2/11/2009Q4 2008($0.13)($0.13)($0.13)
11/13/2008Q3 2008($0.12)($0.12)($0.12)
7/29/2008Q2 2008($0.10)($0.10)($0.10)
5/14/2008Q1 2008($0.09)($0.09)($0.09)
2/19/2008Q4 2007($0.11)($0.11)($0.11)












Compugen Earnings - Frequently Asked Questions

When is Compugen's earnings date?

Compugen has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 27th, 2022 based off last year's report dates. Learn more on CGEN's earnings history.

Did Compugen beat their earnings estimates last quarter?

In the previous quarter, Compugen (NASDAQ:CGEN) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.01. Learn more on analysts' earnings estimate vs. CGEN's actual earnings.

How much revenue does Compugen generate each year?

Compugen (NASDAQ:CGEN) has a recorded annual revenue of $6 million.

How much profit does Compugen generate each year?

Compugen (NASDAQ:CGEN) has a recorded net income of -$34.20 million. CGEN has generated -$0.39 earnings per share over the last four quarters.

What is Compugen's EPS forecast for next year?

Compugen's earnings are expected to decrease from ($0.49) per share to ($0.58) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:CGEN) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.